Role of Erythropoietin in the Correction of Anemia in Patients with Heart Failure

Streeter, Rebecca P.; Mancini, Donna

doi:10.1002/9780470994740.ch14

Search citation statements

Order By: Relevance

Paper Sections

Select...

A N E M I a I N H E A Rt Fa I L U R E1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2007

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 83 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The actual prevalence ranges from 12-61%, depending on HF severity, patient age, patient population, and definition of anemia (68). Nevertheless, many studies strongly support an association between anemia and increased HF mortality (69).…”

Section: A N E M I a I N H E A Rt Fa I L U R Ementioning

confidence: 99%

Evidence-based Treatment of Chronic Heart Failure

2007

View full text Add to dashboard Cite

The past two decades have seen a knowledge explosion in the field of cardiovascular diseases, in general, and in the understanding of chronic heart failure (HF) as a complex neurohumoral syndrome in particular. A new staging system for chronic HF has been developed within the last decade to facilitate the evidence-based prescription of medications and medical devices for each of its four stages. The burden of care for patients with chronic HF is substantially provided in primary care settings. Primary care physicians need to understand the underlying pathophysiology of chronic HF, the elements of its evaluation and treatment by stage, and when referral is necessary.

show abstract

Section: A N E M I a I N H E A Rt Fa I L U R Ementioning

confidence: 99%